● LIVE
NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40
Login☆ Watchlist
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommoditiesIPOs
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingStartupsEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth

VIYASH

BSE
Viyash Scientific Limited
Healthcare· Pharmaceuticals & Biotechnology· INE807F01027· Scrip: 512529
ENहिन्दीગુજરાતીमराठी
251.90
5.40 (+0.00%)
2026-06-10
BSE
251.90
5.40
+0.00%
18720522424326201-2302-1203-0403-2404-2005-0805-2706-10
81 trading days · 1Y period
TODAY (BSE)
Open262.10
High262.75
Low250.95
Prev Close257.30
Volume1.40L
Value₹3.6Cr
L: 250.95H: 262.75
Info
Face Value₹2
Listed2016-03-10
ISININE807F01027
SeriesB
BSE Scrip512529

Key Metrics

1D
1W
1M
3M
6M
Growth (QoQ)
Revenue+6.01%
PAT+2.21%
EPS+40.00%
Profitability
Dividend
Growth+150.00%
TTM Revenue
₹1178 Cr
TTM EBITDA
₹123 Cr
TTM PAT
₹19 Cr
TTM EPS
₹0.38
Rev/Share
₹27.0

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr98 Cr195 Cr293 Cr391 Cr22-1223-0323-0923-1224-0324-0624-0924-12-0.4-3.8-0.30.3-0.00.20.10.1
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-31391 Cr388 Cr42 Cr8 Cr6 Cr0.14
2024-09-30369 Cr361 Cr41 Cr8 Cr6 Cr0.10
2024-06-3058 Cr62 Cr8 Cr6 Cr5 Cr0.18
2024-03-31361 Cr358 Cr33 Cr3 Cr1 Cr-0.04
2023-12-31329 Cr335 Cr20 Cr1 Cr11 Cr0.33
2023-09-30346 Cr359 Cr29 Cr-3 Cr-7 Cr-0.34
2023-03-31367 Cr396 Cr-60 Cr-89 Cr-92 Cr-3.77
2022-12-31375 Cr388 Cr13 Cr-10 Cr-10 Cr-0.36

Shareholding Pattern

CURRENT2026-03-31
61.3%PROMOTER
Promoter61.3%
FII2.9%
DII8.0%
Public38.6%
PROMOTER HOLDING TREND
52.8%24-0952.6%24-1252.6%25-0352.3%25-0961.4%25-1261.4%25-1261.3%26-03

Corporate Actions

Ex-DateTypePurpose
2021-09-08Dividend Dividend - Rs 0.50 Per Share
2019-08-21Dividend Annual General Meeting/Dividend - Rs 0.20 Per Share
2018-04-06Other Scheme Of Arrangement
2017-11-20Dividend Interim Dividend - Re 0.20 Per Share
2016-09-15Other Annual General Meeting

Earnings Transcripts

Price History

DateOpenHighLowCloseVolume
2026-06-10259.95263.70251.05252.3018.17L
2026-06-03250.55251.25241.30248.0025.94L
2026-05-27268.89277.35248.00250.2667.71L
2026-05-26262.94264.70255.85257.3612.82L
2026-05-25247.90262.00247.90260.9624.05L
2026-05-22248.80262.50244.62246.0638.87L
2026-05-21256.80258.00245.50247.5425.50L
2026-05-20233.88268.70231.21251.692.32Cr
2026-05-19228.02232.99225.55228.7311.90L
2026-05-18224.10228.00217.05225.488.45L
2026-05-15229.99231.58223.83224.545.79L
2026-05-14227.00235.40224.16230.4516.33L
2026-05-13215.20227.77215.20225.6010.29L
2026-05-12225.00227.49213.70214.699.27L
2026-05-11218.81228.90216.20225.2315.59L
2026-05-08221.75225.37218.00219.608.61L
2026-05-07222.00233.00219.76221.7522.92L
2026-05-06202.98221.40200.01219.6527.49L
2026-05-05204.75208.00199.88200.578.04L
2026-05-04204.09207.55203.12204.784.91L
2026-04-30207.00208.08202.95203.745.66L
2026-04-29210.12212.83206.51207.214.87L
2026-04-28209.95212.00208.30210.274.83L
2026-04-27207.95210.00207.10208.825.73L
2026-04-24212.00212.00205.06207.156.22L
2026-04-23209.61216.48209.61211.7610.53L
2026-04-22207.00212.28207.00209.616.40L
2026-04-21207.35213.18207.35208.056.81L
2026-04-20208.00210.29206.05207.315.76L
2026-04-17207.00210.98206.05208.2510.77L

Frequently Asked Questions

About

Sequent Scientific Limited, formerly known as Viyash Scientific Limited, is an Indian company incorporated in 1985 and listed on the NSE and BSE. It operates as a leading player in the global animal health sector, specializing in the manufacturing and distribution of veterinary vaccines, particularly for the poultry industry. The company has a significant market presence, with a consolidated turnover of ₹13.69 billion and a market capitalization of approximately ₹29.33 billion, and has expanded its operations through subsidiaries and strategic acquisitions.

BOARD OF DIRECTORS
Manish Gupta
Managing Director
DEPARTED
Kausalya Santhanam
Independent Director
DEPARTED
Narendra Mairpady
Independent Director
Rahul Mukim
Independent Director
DEPARTED
Gregory John Andrews
Additional Director
Hari Babu Bodepudi
Additional Director